oversold, page-7

i got the info off BLT's London investor update from Oct. They listed near term news flow - see below. note tacere deal not listed! it's behind schedule but that's bio - some good stuff not far off

"well for what it's worth - the recent intersuisse london
update (Oct) had the following near term news flow items listed:
Q407 - Graham 099 patent USPTO
Q407 - Nucleonics litigation resolution
Q407/Q108 - IND for HIV T cell to be filed
Q108 - HIV stem cell prelim findings
Q208 - PI trial start HIV T cell

I think having a core group of patient investors is proving to be an asset to BLT as they negotiate the biotech obstacle course.

hopefully santa will bring us something for chrissy"